These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10388176)

  • 21. Mammography screening. Benefits, harms, and informed choice.
    Jørgensen KJ
    Dan Med J; 2013 Apr; 60(4):B4614. PubMed ID: 23651722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalised informed choice on evidence and controversy on mammography screening: study protocol for a randomized controlled trial.
    Roberto A; Colombo C; Candiani G; Giordano L; Mantellini P; Paci E; Satolli R; Valenza M; Mosconi P
    BMC Cancer; 2017 Jun; 17(1):429. PubMed ID: 28629329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits.
    Berrington de González A; Reeves G
    Br J Cancer; 2005 Sep; 93(5):590-6. PubMed ID: 16136033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer screening.
    Sirovich BE; Sox HC
    Surg Clin North Am; 1999 Oct; 79(5):961-90. PubMed ID: 10572546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Women's participation in breast cancer screening in France--an ethical approach.
    Moutel G; Duchange N; Darquy S; de Montgolfier S; Papin-Lefebvre F; Jullian O; Viguier J; Sancho-Garnier H;
    BMC Med Ethics; 2014 Aug; 15():64. PubMed ID: 25127662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cost utility analysis of mammography screening in Australia.
    Hall J; Gerard K; Salkeld G; Richardson J
    Soc Sci Med; 1992 May; 34(9):993-1004. PubMed ID: 1631612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges of informed choice in organised screening.
    Østerlie W; Solbjør M; Skolbekken JA; Hofvind S; Saetnan AR; Forsmo S
    J Med Ethics; 2008 Sep; 34(9):e5. PubMed ID: 18757624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal.
    Hauge IH; Pedersen K; Olerud HM; Hole EO; Hofvind S
    Acta Radiol; 2014 Dec; 55(10):1174-9. PubMed ID: 24311702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit.
    Kerlikowske K
    J Natl Cancer Inst Monogr; 1997; (22):79-86. PubMed ID: 9709281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammographic screening: is the benefit worth the risk?
    Faulkner K
    Radiat Prot Dosimetry; 2005; 117(1-3):318-20. PubMed ID: 16464841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Stockholm Mammographic Screening Trial: Risks and benefits in age group 40-49 years.
    Frisell J; Lidbrink E
    J Natl Cancer Inst Monogr; 1997; (22):49-51. PubMed ID: 9709275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'I just want to be able to make a choice': Results from citizen deliberations about mammography screening in Ontario, Canada.
    Abelson J; Tripp L; Sussman J
    Health Policy; 2018 Dec; 122(12):1364-1371. PubMed ID: 30297301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program.
    Andersson I; Janzon L
    J Natl Cancer Inst Monogr; 1997; (22):63-7. PubMed ID: 9709278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial.
    Frisell J; Lidbrink E; Hellström L; Rutqvist LE
    Breast Cancer Res Treat; 1997 Sep; 45(3):263-70. PubMed ID: 9386870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A meta-analysis of mammographic screening with and without clinical breast examination.
    Hamashima C; Ohta K; Kasahara Y; Katayama T; Nakayama T; Honjo S; Ohnuki K
    Cancer Sci; 2015 Jul; 106(7):812-8. PubMed ID: 25959787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991.
    Burton RC; Bell RJ; Thiagarajah G; Stevenson C
    Breast Cancer Res Treat; 2012 Feb; 131(3):949-55. PubMed ID: 21956213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated mammographic screening reduces breast cancer mortality along the continuum of age.
    Broeders MJ; Verbeek AL; Straatman H; Peer PG; Jong PC; Beex LV; Hendriks JH; Holland R
    J Med Screen; 2002; 9(4):163-7. PubMed ID: 12518006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammographic screening in older women. Is it worthwhile?
    van Dijck JA; Broeders MJ; Verbeek AL
    Drugs Aging; 1997 Feb; 10(2):69-79. PubMed ID: 9061265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating risk of breast cancer from population incidence affected by widespread mammographic screening.
    Taylor R; Boyages J
    J Med Screen; 2001; 8(2):73-6. PubMed ID: 11480447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.